Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study

Gastrointestinal Endoscopy

Volumn 66, Issue 4, 2007, Pages 798-803

  Suk, Ki Tae ^a   Kim, Jae Woo ^a   Kim, Hyun Soo ^a   Baik, Soon Koo ^a   Oh, Seok Jin ^b   Lee, Se Joon ^b   Kim, Ho Gak ^c   Lee, Don Haeng ^d   Won, Yong Hyun ^e   Lee, Dong Ki ^b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Daegu University   (South Korea)

^d Inha University School of Medicine   (South Korea)

^e Taewoong Medical Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGITIS; CHOLECYSTITIS; CLINICAL ARTICLE; DRUG ELUTING STENT; FEMALE; HUMAN; MALE; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BILE DUCT NEOPLASMS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLESTASIS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METALS; MIDDLE AGED; PACLITAXEL; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34648824951     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.05.037     Document Type: Article

References (24)

1. Smith A.C., Dowsett J.F., Russell R.C., et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344 (1994) 1655-1660
2. Wagner H.J., Knyrim K., Vakil N., et al. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 25 (1993) 213-218
3. O'Brien S., Hatfield A.R., Craig P.I., et al. A three year follow up of self expanding metal stents in the endoscopic palliation of long-term survivors with malignant biliary obstruction. Gut 36 (1995) 618-621
4. Lee D.K., Kim H.S., Kim K.S., et al. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest Endosc 61 (2005) 296-301
5. Isayama H., Komatsu Y., Tsujino T., et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc 55 (2002) 366-370
6. Won J.H., Lee J.D., Wang H.J., et al. Effects of a holmium-166 incorporated covered stent placement in normal canine common bile ducts. J Vasc Interv Radiol 16 (2005) 705-711
7. Bezzi M., Zolovkins A., Cantisani V., et al. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction. J Vasc Interv Radiol 13 (2002) 581-589
8. Nakai Y., Isayama H., Komatsu Y., et al. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc 62 (2005) 742-748
9. Park D.H., Kim M.H., Choi J.S., et al. Covered versus uncovered Wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol 4 (2006) 790-796
10. Kim H.S., Lee D.K., Kim H.G., et al. Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study. Gastrointest Endosc 55 (2002) 359-365
11. Kalinowski M., Alfke H., Kleb B., et al. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions. Invest Radiol 37 (2002) 399-404
12. Rowinsky E.K., and Donehower R.C. Paclitaxel (Taxol). N Engl J Med 332 (1995) 1004-1014
13. Dhanikula A.B., and Panchagnula R. Localized paclitaxel delivery. Int J Pharm 183 (1999) 85-100
14. Knyrim K., Wagner H.J., Pausch J., et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 25 (1993) 207-212
15. Yoon J.W., Lee J.K., Lee K.H., et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 63 (2006) 996-1000
16. Hausegger K.A., Thurnher S., Bodendorfer G., et al. Treatment of malignant biliary obstruction with polyurethane-covered Wallstents. AJR Am J Roentgenol 170 (1998) 403-408
17. Bethge N., Wagner H.J., Knyrim K., et al. Technical failure of biliary metal stent deployment in a series of 116 applications. Endoscopy 24 (1992) 395-400
18. Huibregtse K., Carr-Locke D.L., Cremer M., et al. Biliary stent occlusion: a problem solved with self-expanding metal stents?. European Wallstent Study Group. Endoscopy 24 (1992) 391-394
19. Hausegger K.A., Kleinert R., Lammer J., et al. Malignant biliary obstruction: histologic findings after treatment with self-expandable stents. Radiology 185 (1992) 461-464
20. Shin J.H., Song H.Y., Choi C.G., et al. Tissue hyperplasia: influence of a paclitaxel-eluting covered stent: preliminary study in a canine urethral model. Radiology 234 (2005) 438-444
21. Kahaleh M., Tokar J., Conaway M.R., et al. Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 61 (2005) 528-533
22. Born P., Neuhaus H., Rösch T., et al. Initial experience with a new, partially covered Wallstent for malignant biliary obstruction. Endoscopy 28 (1996) 699-702
23. Pisters P.W., Hudec W.A., Lee J.E., et al. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. J Clin Oncol 18 (2000) 860-867
24. Simmons D.T., Baron T.H., Petersen B.T., et al. A novel endoscopic approach to brachytherapy in the management of hilar cholangiocarcinoma. Am J Gastroenterol 101 (2006) 1792-1796